Product Information
KARIVA 28 DAY TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1493 per EA under NDC 00555905058. Its NADAC has been published 657 times since Nov 28, 2013.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555905058
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA075863On Market Since
4/8/2002
Price Statistics
The NADAC for KARIVA 28 DAY TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 86.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1493 per EA |
|---|---|
| All-time high | $1.1046 (Mar 12, 2014) |
| All-time low | $0.1319 (Apr 17, 2024) |
| 52-week high | $0.2029 |
| 52-week low | $0.1493 |
| Median price | $0.4759 |
| Average price | $0.5133 |
| Largest weekly change | +42.3% (Nov 22, 2023) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Desogestrel/Ethinyl Estradiol and Ethinyl Estradiol market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of KARIVA 28 DAY TABLET?
The current National Average Drug Acquisition Cost (NADAC) for KARIVA 28 DAY TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.1493 per EA (NDC 00555905058), effective Jun 24, 2026.
How has the price of KARIVA 28 DAY TABLET changed over time?
Over the history we have for it, the NADAC for KARIVA 28 DAY TABLET has declined 86.3%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for KARIVA 28 DAY TABLET?
Since Nov 28, 2013, the NADAC for KARIVA 28 DAY TABLET has ranged from a low of $0.1319 (Apr 17, 2024) to a high of $1.1046 (Mar 12, 2014), with a median of $0.4759 per EA.
Are there cheaper alternatives to KARIVA 28 DAY TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of KARIVA 28 DAY TABLET, so no direct lower-cost alternative is listed.
Who manufactures KARIVA 28 DAY TABLET?
KARIVA 28 DAY TABLET (NDC 00555905058) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification